Ashleigh has worked at the Burnet Institute since 2017 and is a public health epidemiologist and post-doctoral research fellow. Ashleigh works across the Disease Elimination and Harm and Risk Reduction at the Burnet. Her research focuses on viral hepatitis elimination among people with HIV and drug-related harms among people who inject drugs. Ashleigh specialises in longitudinal data and linked administrative data analysis.
In 2022–2023, Ashleigh was appointed as a research fellow at the Victorian Institute of Forensic Medicine, working in collaboration with the UN Special Rapporteur for Extrajudicial, Summary and Arbitrary Executions. Her work was related to monitoring and preventing deaths in custody.
Ashleigh completed her PhD at the Burnet Institute in 2022, where she explored mental health morbidity and service access among men leaving prison who reported a history of injecting drug use. Ashleigh also has a background in clinical nursing working as a registered nurse, specialising in mental health.
Key research interests include: infectious disease epidemiology, hepatitis C elimination, injecting drug use, drug-related harms, supervised injecting rooms, women’s health.
JAIDS Journal of Acquired Immune Deficiency Syndromes
Rachel Sacks‐Davis, Ashleigh C. Stewart, Daniela K van Santen, Joseph Doyle, Mark Stoové, Margaret Hellard
BMJ Open
Dylan Vella-Horne, Ashleigh C. Stewart, Matthew Hickman, Paul A. Agius, Nick Scott, Amanda Roxburgh, Daniel O’Keefe, Peter Higgs, Mark Stoové, Zachary Lloyd
BMJ Open
Dylan Vella-Horne, Ashleigh C. Stewart, Matthew Hickman, Paul A. Agius, Nick Scott, Amanda Roxburgh, Daniel O’Keefe, Peter Higgs, Mark Stoové, Zachary Lloyd
This is a multinational longitudinal cohort of people living with HIV who are at risk of hepatitis C virus infection or infected with the hepatitis C virus.
A cohort study of people who inject drugs and who use the Melbourne Supervised Injecting Rooms.
The largest and longest-running active cohort study of people who inject drugs in Australia (since 2008).